Skip to Main Content


Skip Nav Destination

Chimeric peptides: a new approach to enhancing the immunogenicity of peptides with low MHC class I affinity: application in antiviral vaccination.

J Immunol (1997) 159 (5): 2391–2398.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal